基本信息
views: 35
Career Trajectory
Bio
Dr. Berger provides statistical review of Division of Cancer Prevention (DCP) protocols and concepts and conducts methodological research related to the design and analysis of randomized trials. His research interests focus primarily on internal validity and biases, and he led the effort to develop a web-based tool that automates the execution of Maximally-Tolerated-Imbalance (MTI) randomization. The tool permits creation of allocation sequences for any real-world trial.
Research Interests
Papers共 225 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
PHARMACEUTICAL STATISTICS (2024)
Pharmaceutical statisticsno. 3 (2024): 425-428
Wenle Zhao,Kerstine Carter,Oleksandr Sverdlov, Annika Scheffold,Yevgen Ryeznik,Christy Cassarly,Vance W. Berger
STATISTICS IN MEDICINEno. 6 (2024): 1194-1212
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2023)
Statistics in Biopharmaceutical Researchpp.1-15, (2023)
Kerstine Carter, Annika L. Scheffold,Jone Renteria,Vance W. Berger,Yuqun Abigail Luo,Jonathan J. Chipman,Oleksandr Sverdlov
STATISTICS IN BIOPHARMACEUTICAL RESEARCHpp.1-13, (2023)
Principles and Practice of Clinical Trialspp.1851-1867, (2022)
BMC medical research methodologyno. 1 (2021): 168-168
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn